EXPERIMENTAL TREATMENTS
Peptides for Longevity After 45: What the Evidence Really Says
Peptides include both authorized medicines and products promoted far beyond their evidence. The useful distinction is the exact product, indication and human research, not whether something is described as a peptide.
Authorization and evidence for the exact peptide
Health Canada warns against unauthorized injectable peptides marketed for wellness, recovery or anti-aging. Labels such as “research grade” do not establish safety for people.
Evidence for an authorized peptide medicine in a defined condition does not validate BPC-157, CJC-1295 or another product sold for general longevity. Clinic monitoring also cannot supply missing evidence of benefit.
Check the product, use and human outcomes
Identify the exact claim
Why it matters: The broad peptide label can obscure major differences.
Practical application / what to track: Record the product, route and intended condition rather than relying on a category claim.
Check authorization
Why it matters: Availability through a website or clinic does not prove authorization.
Practical application / what to track: Ask a pharmacist to check the exact product and approved use in your jurisdiction.
Read human outcomes
Why it matters: Animal results cannot establish a personal treatment plan.
Practical application / what to track: Ask whether controlled human trials measured a meaningful benefit and reported harms.
Consider alternatives
Why it matters: The concern behind the purchase may have established assessment or treatment options.
Practical application / what to track: Bring the recovery, pain or metabolic question to your clinician before considering a product.
Avoid copying online injection protocols
- Treating “research use only” as a quality guarantee.
- Assuming an approved medicine validates all peptides.
- Copying injection or dosing instructions from online protocols.
If you have used an unauthorized product and feel unwell or have concerns, contact a healthcare professional promptly. Seek emergency help for severe symptoms.
Primary care discussion checklist
Use the questions that fit your situation. Keep personal health notes private and bring them through your clinic’s approved channel.
- What established assessment or treatment fits my underlying concern?
- Is this exact product authorized for the proposed use?
- What evidence, risks and alternatives should we discuss?
Next steps and related reading
Take the exact product name, proposed use and advertising claim to the peptide discussion checklist. Ask your clinician or pharmacist about authorization, evidence and alternatives; this guide supplies no purchasing or dosing protocol.
Educational guidance. Not medical advice.
Rapamycin and Metformin After 45: What Longevity Research Really Shows
Compare the research questions and limits behind claims about these medicines.
Senolytics After 45: What to Know About “Zombie Cells” and Healthy Aging
Learn what senescent cells are and where senolytic research remains uncertain.
Advanced Biomarker Tests After 45: What’s Worth Tracking?
Use the clinical discussion checklist to ask what a test result would change.
Evidence & Primary Sources
Original references and further reading are retained below. These include research and educational resources; inclusion is not a study-level appraisal or endorsement. See our evidence and editorial policy.
Authorship and editorial disclosures. This editorial update does not claim a new independent medical review. Report a correction.
FREE LIVING WELL STARTER KIT
Choose one useful next step.
A completed example, a two-week plan and tracker, plus an optional appointment sheet. Free to use without signing up.
Four printable or fillable pages. Choose one action that fits your life.